[go: up one dir, main page]

YU25096A - Inhibicija fotodekompozicije 3-supstituisanog-2-oksindola - Google Patents

Inhibicija fotodekompozicije 3-supstituisanog-2-oksindola

Info

Publication number
YU25096A
YU25096A YU25096A YU25096A YU25096A YU 25096 A YU25096 A YU 25096A YU 25096 A YU25096 A YU 25096A YU 25096 A YU25096 A YU 25096A YU 25096 A YU25096 A YU 25096A
Authority
YU
Yugoslavia
Prior art keywords
substituted
decomposition
oxindol
inhibition
photo
Prior art date
Application number
YU25096A
Other languages
English (en)
Inventor
Willard Newlin
Sharon Laughlin
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of YU25096A publication Critical patent/YU25096A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883Capsule finishing, e.g. dyeing, aromatising, polishing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polymerisation Methods In General (AREA)
  • Macromonomer-Based Addition Polymer (AREA)

Abstract

Ovaj pronalazak se odnosi na zaštitu navedenog 3-supstituisanog-2-oksindol-1-karboksamida formule i njegove farmaceutski prihvatljive bazne soli u kome X je H, Cl ili F; Y je H ili Cl; i R je benzil ili tienil, svaki opciono supstituisan sa Cl ili F od dekompozicije u prisustvu svetla.
YU25096A 1995-04-24 1996-04-23 Inhibicija fotodekompozicije 3-supstituisanog-2-oksindola YU25096A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Publications (1)

Publication Number Publication Date
YU25096A true YU25096A (sh) 1998-08-14

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
YU25096A YU25096A (sh) 1995-04-24 1996-04-23 Inhibicija fotodekompozicije 3-supstituisanog-2-oksindola

Country Status (30)

Country Link
EP (1) EP0827399A1 (sh)
JP (1) JPH10506635A (sh)
KR (1) KR100189585B1 (sh)
CN (1) CN1053667C (sh)
AP (1) AP607A (sh)
AR (1) AR002728A1 (sh)
AU (1) AU692378B2 (sh)
BG (1) BG100531A (sh)
BR (1) BR9602024A (sh)
CO (1) CO4700418A1 (sh)
FI (1) FI973988A0 (sh)
HR (1) HRP960194A2 (sh)
HU (1) HU216544B (sh)
IL (1) IL117969A0 (sh)
IS (1) IS4339A (sh)
MA (1) MA23848A1 (sh)
NO (1) NO961622L (sh)
NZ (1) NZ286432A (sh)
OA (1) OA10286A (sh)
PE (1) PE34397A1 (sh)
RO (1) RO113305B1 (sh)
RU (1) RU2109510C1 (sh)
SG (1) SG64924A1 (sh)
SI (1) SI9600133A (sh)
SK (1) SK51296A3 (sh)
TR (1) TR199600300A2 (sh)
UA (1) UA42739C2 (sh)
WO (1) WO1996033701A1 (sh)
YU (1) YU25096A (sh)
ZA (1) ZA963210B (sh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2758128C1 (ru) 2017-12-29 2021-10-26 Крафт Фудс Груп Брэндс Ллк Улучшенная устойчивость к окислению эмульсий типа "масло в воде" при помощи натуральных стабилизаторов

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3136282A1 (de) * 1981-09-12 1983-03-24 Hoechst Ag "verfahren zur stabilisierung photoinstabiler arzneistoffe sowie stabilisierte arzneizubereitungen"
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
WO1996033701A1 (en) 1996-10-31
BG100531A (bg) 1997-06-30
HUP9601057A2 (en) 1997-04-28
AP9600787A0 (en) 1996-04-30
SK51296A3 (en) 1997-04-09
KR960037656A (ko) 1996-11-19
UA42739C2 (uk) 2001-11-15
IS4339A (is) 1996-10-25
FI973988A7 (fi) 1997-10-17
HU9601057D0 (en) 1996-06-28
NO961622L (no) 1996-10-25
RU2109510C1 (ru) 1998-04-27
AU5085196A (en) 1996-11-07
EP0827399A1 (en) 1998-03-11
SG64924A1 (en) 1999-05-25
HU216544B (hu) 1999-07-28
HRP960194A2 (en) 1998-02-28
TR199600300A2 (tr) 1996-11-21
CN1053667C (zh) 2000-06-21
BR9602024A (pt) 1998-10-06
ZA963210B (en) 1997-10-23
PE34397A1 (es) 1997-09-29
HUP9601057A3 (en) 1997-05-28
AR002728A1 (es) 1998-04-29
FI973988L (fi) 1997-10-17
CN1139110A (zh) 1997-01-01
CO4700418A1 (es) 1998-12-29
KR100189585B1 (ko) 1999-06-01
NO961622D0 (no) 1996-04-23
MA23848A1 (fr) 1996-12-31
IL117969A0 (en) 1996-08-04
JPH10506635A (ja) 1998-06-30
NZ286432A (en) 1998-05-27
RO113305B1 (ro) 1998-06-30
SI9600133A (en) 1996-10-31
AP607A (en) 1997-08-27
OA10286A (en) 1997-09-19
AU692378B2 (en) 1998-06-04
FI973988A0 (fi) 1997-10-17

Similar Documents

Publication Publication Date Title
CO4230019A1 (es) Antagonistas de neuroquinina diazabiciclica
YU35697A (sh) Supstituisani 6,6-hetero-biciklični derivati
EA200000391A1 (ru) Производные тиенопиримидина и тиенопиридина, полезные в качестве противораковых агентов
AR038429A2 (es) Compuestos 15-alquil-16-hidroxilo de marcfortina
ID27652A (id) Turunan amida yang digunakan sebagai inhibitor produksi sitokina
ES2138622T3 (es) Derivados de mercaptoacetilamido piridazo(1,2-a)(1,2)diazepina utilizados como inhibidores de encefalinasa y eca.
AP2002002637A0 (en) Novel piperazine
DE69613985D1 (de) Meta-guanidine, harnstoff, thioharnstoff oder azacyklische aminobenzoesäure-derivate als integrin antagonisten
ATE233274T1 (de) Oxyiminopregnancarbolactone
SE9504661D0 (sv) New compounds
FI951245A7 (fi) Liuosten muodostaminen
KR950701911A (ko) 피페리딘 유도체를 유효성분으로 하는 말초혈관확장제(peripheral vaso-dilating agent containing piperidine derivative as active ingredient)
DE69405732D1 (de) Herstellung von perfluor(alkylvinylethern)
UY24625A1 (es) Derivados de la 4-hidroxi-piperidina
YU17301A (sh) KRISTALNI OBLICI EtO2C-CH2-(R)-Cgl-Aze-Pab-OH
ATE224372T1 (de) Substituierte 6-alkylphenanthridine
ES2152379T3 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos.
FI931023A7 (fi) Uusia b-aminohappojohdannaisia
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
YU48915B (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
DE69325073D1 (de) Borazinderivate von Hydridopolysilazanpolymeren
NO982229D0 (no) Svovelholdige di-tert-butylfenol-forbindelser anvendbare som antiinflammatoriske midler
YU25096A (sh) Inhibicija fotodekompozicije 3-supstituisanog-2-oksindola
SE9504662D0 (sv) New compounds
CA2032797A1 (en) Antithrombotic compounds